fda retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation RETATRUTIDE (RETA) – Research Peptide

Includes TB-500 and BPC-157

Safe Use of Glutathione When incorporating glutathione as a supplement, it is essential to follow safe practices to avoid potential side effects

A cross-sectional study based on NHANES 2003-2004 data from 2,638 participants ages 40 years and over found that the risk of high blood pressure (hypertension), a major contributing factor for CVD, was 73% higher in individuals in the upper versus lowest quintile of serum selenium concentrations (150 g/L vs

There is no doubt that the addition of WeightWatchers breakthrough GLP-1 companion programme will add enormously to our patients ability to achieve sustainable weight loss through its science-backed and proven programmes, together with their global community of like-minded individuals

Clinical trials show average weight loss of 5-10% of body weight over 56 weeks with liraglutide 3.0 mg daily, compared to tirzepatide at 20-22%